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ABSTRACT 
Dengue Hemorrhagic Fever (DHF) is caused by four variants of the Dengue Hemorrhagic 
Fever (DHF) virus of the Flaviviridae family (DENV-1, DENV-2, DENV-3, and DENV-4). 
These four variants are indistinguishable clinically. The occurrence of platelet deterioration is 
sometimes not accompanied by positive IgG and IgM DHF results, nor can they be negative. 
In DHF sufferers, platelet decline will decrease steadily during the 3rd to 6th day and will 
increase on the 7th day. This research is retrospective analytical with cross sectional 
approach. The samples were 15 patients of Secondary DHF and 15 Primary DHF who have 
fulfilled the inclusion criteria. The day of fever when the patient came to the Poli Internal 
Medicine Dr. Soetomo Hospital is known from the patient's history, while the results of IgG 
and IgM DHF examination and platelet count are performed in KLINIKA Surabaya 
laboratory. The result of this study used correlation parametric test (Pearson's test), to know 
the relationship of day of fever and platelet count in Secondary and Primary DHF patients 
with α = 0,05. Result of day of fever with p = .659 (p>0.05). The result of thrombocyte count 
with Pearson's test (p= .042) (p<0.05) showed a correlation of platelet count between 
Secondary and Primary DHF patients. It was concluded that there was a significant 
correlation the number of platelets between Secondary and Primary DHF. 
 





The number of Dengue Hemorrhagic Fever 
in 2014 until mid-December recorded in 34 
provinces in Indonesia as many as 71,668 
people, and 641 of them died. This figure 
is lower than the previous year, in 2013 
with the number of people as many as 
112,511 people and the number of cases 
died as many as 871 people (Balitbangkes, 
2015). 
Dengue virus until now known 4 serotypes 
DENV-1, DENV-2, DENV-3, and DENV-
4 included in Arthropod Borne Virus 
(Arbovirus) group B family Flaviviridae. 
All four serotypes of this virus have been 
found in various regions in Indonesia. 
Research in Indonesia show that Dengue-3 
is closely related to severe dengue cases 
and is the most widely distributed followed 
by Dengue-2, Dengue-1 and Dengue-4 
serotype. Incubation period usually ranges 
from 4-7 days followed by a sudden high 
fever lasting for 2-7 days. Fever can come 
down on the 3rd day then up again, and on 
the 6th or 7th day the fever suddenly goes 
down (Setiati TE, 2006; C.P. Simmons, 
2012).    
Thrombocyte count is usually found during 
illness between 3-7 days to about 100,000 / 
mm3. Platelet count decreases in patients 
who have been tested positive for IgG and 
IgM DHF or just IgG DHF or IgM DHF. 
Patients with negative both IgG and IgM 
DHF outcomes how the impression of 
platelet count. So far, no researcher has 
examined platelet count in patients with 
--- 503 ---
Proceeding of Surabaya International Health Conference
July 13-14, 2017
secondary and primary DHF. Also is there 
day of fever difference with the decrease in 
platelet counts in secondary and primary 
DHF. 
The sample of the study was obtained from 
inpatients in RSUD Dr. Soetomo, and 
platelet test were performed by Sysmex 
KX-21 and IgG and IgM DHF levels were 
performed with Bioline rapid test, and the 
days of fever were recorded on the patient 
arrival to the Hospital. 
 
MATERIAL AND METHOD 
This research is an observational analitic 
with cross sectional approach. The 
population of the study were all patient of 
Tropic Infection RSUD Dr. Soetomo 
Surabaya. All patients with fever were 
noted the day of fever, then IgG and IgM 
DHF were examined with Rapid Test, then 
into 2 groups with IgG and IgM DHF 
positive, and IgG or IgM positive.is 
classified as secondary DHF infection, and 
patients with IgG and IgM DHF negative, 
are classified as primary DHF infection. 
The total sample size was 30 where the 
patients with secondary DBD and primary 
DBD were each 15 samples. The reagents 
used are Rapid test IgG and IgM DHF SD 
Bioline. Platelet examination is done 
automatically with Sysmex KX 21 in 
Klinika laboratory. 
 






Figure 4.1 Hitogram Age of respondents 
where seen in the age group 17-21 years is 
the highest suffer from fever of secondary 
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Figure 4.2 Histogram Gender of 
respondents which seen in the group Men 
as many as 21 patient or 70% is highest 
suffered from secondary and primary DHF, 
while in the group of women as many as 9 




Figure 4.3 Hitogram The day of fever of 
the primary DHF patient, which was seen 
in the 5th day of fever group of 7 patient or 
46.7% (7/15) was the highest day of fever 





Figure 4.4 Hitogram The day of fever 
during secondary DHF patient, which was 
seen 5 people in the 5th Day of fever or 
33.3% (5/15) was the highest day of fever 




Figure 4.5 Hitogram platelet count in 
primary DHF patient, where seen in the 
platelet count group of 100,000-124,000 as 
many as 6 patient or 40% is the highest 






Figure 4.5 Hitogram Thrombocyte count in 
the secondary DBD patient, where seen in 
the platelet count group 25,000-49,000 as 
many as 6 patient or 40% is the highest 



















Kendall's and Spearman's non parametric 
test results showed days of fever in 
secondary DBF patients and primary DHF 
there was no correlation in which Kendall's 
correlation coefficient test = -0.217; p = 
0.196 (p>0.05) and Spearman's test 
correlation coefficient = -0.240; p = 0.201 
(p>0.05) with weak correlation strength. 
Whereas the number of platelets in 
secondary and primary DHF there is a 
correlation in which the results with 
Kendall's correlation coefficient test = -
0.373; p = 0.016 (p<0.05) and Spearman's 
test correlation coefficient = -0,447; p = 
0.013 (p<0.05) show negative correlation 
with strong correlation strength. 
 
DISCUSSION 
The mean age of secondary DHF and 
primary-DHF patients was the subject of 
this study 25.4 years and the most sex were 
male, this result was in accordance with 
Endo Dardjito 2005 results in which age > 
15 years and 72% were Men as much as 
58%. 
The result of the day of fever shows no 
significant correlation in secondary DHF 
and primary DHF patients, but the most the 
day of fever that came to RSUD Dr. 
Soetomo that after experiencing the fever 
on the 5th day, this result is also obtained 
on the research Andi Alfia in 2011. It can 
be concluded that the people believes that 
if the day of fever of the fifth day does not 
go down and down, worrying about 
suffering from dengue fever. One of the 
typical symptoms of dengue fever is 2-7 
days. These symptoms appear as the body's 
response to dengue virus infection and as 
the body's defense mechanism against 
DHF virus (Mayeti, 2010; Rena, 2009). 
 
Result of research of platelet count in 
patient primary DHF got result of platelet 
count between 100.000-124.000 / mm3 and 
in secondary DHF sufferer got result of 
platelet count most between 25.000-49.000 
and this result almost same with result of 
research of Putu Diani Wirayanti 2015 in 
patients with dengue fever degree I 
obtained 103000 / mm3 platelet mean and 
in dengue hemorrhagic patients grade II 
obtained mean platelet count were 94.000 / 
mm3. From the results of this study the 
number of platelets between secondary 
DHF and primary DHF patients who come 
to the hospital on the 5th day is very 
different meaningful. This suggests that in 
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secondary DHF patients the number of 
platelets count decreased to 25.000 / mm3 
as a result of a second infection with 
different DHF virus variants. A natural 
infection by one of the four DENV 
Serotypes (DENV-1, DENV-2, DENV-3, 
DENV-4) produces long-lasting immunity 
to reinfection by the same serotype, but the 
heterotypic protection is temporary. This 
condition is called in primary infection as 
seen in patients with dengue fever that 
looks fresh and there are some people are 
not aware that he was once infected with 
the virus Dengue. In this case it may be 
that IgG and IgM levels have not formed 
or are only positive for DHF IgM alone. In 
the second infection, both IgG and IgM-
positive IgG or IgM DHF results from IgM 
DHF acute phase have passed and most of 
these individuals will develop more severe 
DHF or DSS as a result of being infected 
by a serotype different from the first DHF 
infection serotype. This situation indicates 
that previous dengue infection has 
developed antibody-dependent 
enhancement (ADE) is a risk factor for 
developing more severe disease (Halstead, 
1988; Cummings DAT, 2005). 
In the body, the primary DHF virus 
antibody infects will recognize the second 
viral antigen DHF infection, resulting in 
antibody antigen bonds that will interact 
with complement, causing permeability of 
blood vessels (the ability of blood vessel 
walls penetrate the liquid), so that some 
components of fluid and white blood cells 
outward to body tissues, and platelet 
function to the wound of body platelets 
decreases. These events cause the results of 
blood tests found thrombocytopenia 
(decreased platelet count), leukopenia 
(decreased white blood cell count), and 
increased hemotocrit (increased blood cell 
concentration due to reduced blood fluid to 
the tissues) (BA Bouchard, 2001). Due to 
thrombocytopenia, people with Dengue 
virus infection have a blood clotting 
disorder that often encountered red spots 
on the skin called petechiae. Patients are 
also susceptible to bleeding such as 
bleeding gums, nosebleeds, and 




Based on data presentation and discussion, 
it can be concluded that the day of fever  
correlates positively but not significant in 
secondary and primary DHF patients, but 
for platelet count there is negative and 
significant correlation in secondary and 
primary DHF patient. This shows the faster 
the number of decreased platelets occur, 
meaning the stage of dengue suffered more 
severe in secondary stage DHF is more 
severe than the primaryl DHF. 
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